Psoriatic arthritis (PsA) is a chronic autoimmune disorder that affects the joints and skin. It is a type of inflammatory arthritis that is associated with psoriasis, a common skin condition. PsA is a complex condition that can be difficult to diagnose and manage. This article aims to provide an overview of PsA and discuss current treatment and management strategies.
Psoriatic arthritis is a form of inflammatory arthritis that affects the joints and skin. It is an autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy cells and tissues. In PsA, the immune system attacks the joints and skin, leading to inflammation and pain. PsA is closely associated with psoriasis, a common skin condition. Approximately 30% of people with psoriasis also develop PsA. The two conditions often occur together, and symptoms of PsA often appear before or at the same time as psoriasis.
The symptoms of PsA vary from person to person, and can range from mild to severe. Common symptoms include: • Joint pain, stiffness, and swelling • Fatigue • Tenderness in the joints • Swelling of the fingers and toes • Nail changes, such as pitting or discoloration • Skin changes, such as redness or scaling
The diagnosis of PsA can be difficult, as the symptoms can be similar to other types of arthritis. To diagnose PsA, a doctor will take a detailed medical history, perform a physical exam, and order blood tests and imaging tests. The doctor may also refer the patient to a rheumatologist, a doctor who specializes in treating arthritis and autoimmune disorders. The rheumatologist can help to confirm the diagnosis and develop a treatment plan.
The goal of treatment for PsA is to reduce inflammation and pain, and improve function and quality of life. Treatment options include: • Non-steroidal anti-inflammatory drugs (NSAIDs): These medications can help to reduce pain and inflammation. • Disease-modifying antirheumatic drugs (DMARDs): These medications can help to slow the progression of the disease and reduce inflammation. • Biologic agents: These medications target specific parts of the immune system to reduce inflammation and slow the progression of the disease. • Corticosteroids: These medications can help to reduce inflammation and pain. • Physical therapy: Physical therapy can help to improve joint function and reduce pain.
In addition to medications, lifestyle changes can also help to manage PsA. These include: • Regular exercise: Exercise can help to reduce pain and stiffness, and improve joint function. • Stress reduction: Stress can worsen the symptoms of PsA, so it is important to find ways to manage stress. • Healthy diet: Eating a healthy diet can help to reduce inflammation and improve overall health. • Weight management: Being overweight can worsen the symptoms of PsA, so it is important to maintain a healthy weight.
Psoriatic arthritis is a complex condition that can be difficult to diagnose and manage. Treatment and management strategies include medications, physical therapy, and lifestyle changes. By understanding the symptoms and treatment options, people with PsA can work with their healthcare team to find the best treatment plan for their individual needs.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation